Quell Therapeutics Demonstrates Safety, Phenotypic Stability, Durability and Early Efficacy with Phenotype‑Locked™ CAR‑Tregs in LIBERATE Phase 1/2 Liver Transplant Study

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious ...
Cryptopolitan on MSN

The "Aave Will Win" proposal has passed Temp Check with 52.58% approval

Aave’s infamous “Aave Will Win” funding proposal just cleared its first major governance hurdle today, March 1, 2026, after obtaining a slim 52.58% approval, but ACI founder Marc Zeller wasted no time ...
InfoQ

Google Enhances Node Pool Auto-Creation Speed for GKE Clusters

Google Cloud has optimised GKE's node pool auto-creation, significantly cutting "Time to Ready" for massive clusters. By ...
Jacksonville Daily Record

Southbank Hotel by Marriott upgrading in $2 million project

A few years into new branding, the 45-year-old Southbank hotel that now is a Delta by Marriott franchise is completing a ...